Argitalpenak (39) SARA CALVO SIMAL argitalpenak

2024

  1. A Proposal for Neurography Referral in Patients with Carpal Tunnel Syndrome Based on Clinical Symptoms and Demographic Variables of 797 Patients

    Diagnostics, Vol. 14, Núm. 3

  2. Impact of the COVID-19 pandemic on implantation of cardiac implantable electronic devices and remote monitoring activations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 243-253

  3. Validation of ActiGraph and Fitbit in the assessment of energy expenditure in Huntington's disease

    Gait and Posture, Vol. 109, pp. 89-94

2023

  1. Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease

    Movement Disorders Clinical Practice, Vol. 10, Núm. 2, pp. 279-284

  2. How can I assess my patients with Parkinson's disease during a busy clinic day?

    Parkinsonism and Related Disorders, Vol. 114

  3. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus

    Pharmacogenomics, Vol. 24, Núm. 12, pp. 651-663

2022

  1. Accelerometer Cut-Points for Physical Activity Assessment in Adults with Mild to Moderate Huntington’s Disease: A Cross-Sectional Multicentre Study

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 22

  2. Development of a Predictive Model for the Diagnosis of Lower Urinary Tract Obstruction in Men

    The Journal of urology, Vol. 208, Núm. 3, pp. 668-675

  3. Evolution of patients with chronic hepatitis C infection with advanced fibrosis or cirrhosis cured with direct-acting antivirals. Long-term follow-up

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 10, pp. 767-779

  4. Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington’s disease

    Neurological Sciences, Vol. 43, Núm. 10, pp. 6079-6085

  5. To Resurface or Not to Resurface the Patella in Total Knee Arthroplasty, That Is the Question: A Meta-Analysis of Randomized Controlled Trials

    Medicina (Lithuania), Vol. 58, Núm. 2

2021

  1. Can plasma α-synuclein help us to differentiate parkinson’s disease from essential tremor?

    Tremor and Other Hyperkinetic Movements, Vol. 11

  2. Correction: Can plasma α-synuclein help us to differentiate parkinson’s disease from essential tremor?

    Tremor and Other Hyperkinetic Movements, Vol. 11

  3. Plasma acyl-carnitines, bilirubin, tyramine and tetrahydro-21-deoxycortisol in Parkinson's disease and essential tremor. A case control biomarker study

    Parkinsonism and Related Disorders, Vol. 91, pp. 167-172

  4. The Impact of Dietary Intake and Physical Activity on Body Composition in Parkinson's Disease

    Movement Disorders Clinical Practice, Vol. 8, Núm. 6, pp. 896-903

  5. The minimal clinically important change in the motor section of the Burke-Fahn-Marsden Dystonia Rating Scale for generalized dystonia: Results from deep brain stimulation

    Parkinsonism and Related Disorders, Vol. 93, pp. 85-88

2020

  1. Survival in Restless Legs Syndrome: An 11-Year Surveillance, Community-Based Population Study

    Neuroepidemiology, Vol. 54, Núm. 5, pp. 375-382

  2. Translation, Validation, Diagnostic Accuracy, and Reliability of Screening Questionnaire for Parkinsonism in Three African Countries

    Journal of Parkinson's Disease, Vol. 10, Núm. 3, pp. 1113-1122

2019

  1. Cavicavenmi: Quality of Life Survey in Non-muscle-invasive Bladder Cancer Patients

    Urologia Colombiana, Vol. 28, Núm. 2, pp. 161-168

  2. Clinical manifestations of homozygote allele carriers in Huntington disease

    Neurology, Vol. 92, Núm. 18, pp. E2101-E2108